A risk-based approach is recommended for analytical method comparability for HPLC assay and impurities methods.
Hui Fang
Advertisement
Hui Fang is a senior scientist at Eisai.
Articles by Hui Fang
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Leveraging an Innovative Mid-Scale Manufacturing Solution to Meet Diverse Needs
2
Viral Safety 2.0: Plant-Ready Actions for ICH Q5A(R2) Compliance
3
Faster Doesn’t Mean Easier: Development Impacts of a New Biosimilar Regulatory Landscape
4
A Pharma Manufacturing Blueprint from Delaware’s Innovation Vision
5